GRANADILLO PEDRO P 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
GRANADILLO PEDRO P
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-22$13.93/sh+5,026$70,012→ 5,026 totalExercise: $21.56Exp: 2033-06-22→ Common Stock (5,026 underlying) - Award
Stock Option (Right to Buy)
2023-06-22+25,850→ 25,850 totalExercise: $21.56Exp: 2033-06-22→ Common Stock (25,850 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.
- [F2]This option represents a right to purchase a total of 5,026 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000.